Smartphone app and local health workers team up to fight heart disease
NCT ID NCT05511701
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program that combines a mobile health app, community health workers, and text message reminders to help people lower their risk of heart disease. About 968 adults in Argentina who are at high risk will take part. The goal is to see if this approach can improve blood pressure, cholesterol, and overall heart health over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mHealth app, community health worker visits, electronic decision support, SMS reminders, and point-of-care cholesterol testing
- What this could lead to
- If successful, this could provide a practical, low-cost way to reduce heart disease risk in underserved communities using mobile technology and local health workers.
- What could go wrong
- This is a behavioral intervention trial, not a drug study, so results may vary by setting. The 12-month follow-up is relatively short, and long-term benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Iecs Instituto de Efectividad Clinica Y Sanitaria
Buenos Aires, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drop of blood predict disease years before it strikes?
- A simple bedside score may flag heart patients at risk after surgery — a large study puts it to the test
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- Could a common gout pill protect hearts in HIV?
- New heart valve device aims to fix tricuspid leak without open surgery
- New dialysis filter aims to cut inflammation and protect hearts in kidney patients